Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Barer & Son Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 3
Rounds per year 1.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 2
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Diagnostics
  • Therapeutics
  • Biopharma
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Barer & Son Capital:
Typical Co-investors
Barer & Son Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Barer & Son Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Agate Medical Investments Israel, Tel Aviv, Tel Aviv District
AnswersMedia Chicago, Illinois, United States
Asgard Capital Brandenburg, Germany, Potsdam
China and Portuguese-speaking Countries Cooperation and Development -
China Merchants Technology Holdings China, Guangdong, Shenzhen
Cobre Capital Arizona, Scottsdale, United States
COERA Cluj, Cluj-Napoca, Romania
London & Scottish Investment Partners City of Edinburgh, Scotland, United Kingdom
MTI Japan, Shinjuku
Sagus Capital Partners Incline Village, Nevada, United States
Shanghai Anting Industrial Development Co., Ltd. China, Shanghai
SIDBI Innovation & Incubation Centre (SIIC) India, Kanpur, Uttar Pradesh
SMS Securities Switzerland, Zürich, Zurich
SR Innovation Exchange India, Telangana, Warangal
TukkuHeino -
Wealth Well Ar Riyad, Riyadh, Saudi Arabia
Xpreneurs Bayern, Germany, München
Zhili Zhenzhu -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$35M24 Jun 2020 Baltimore, Maryland, United States

Biopharma
Biotechnology
Health Diagnostics
Medical
Wellness
$75M18 Jun 2019 Maryland, United States

NexImmune

Biopharma
Biotechnology
Therapeutics
$23M02 Jan 2018 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Barer & Son Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 34M
Rounds per year 1.00
Peak activity year 2018
Lead investments 2
Follow on index 0.25
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AsclepiX Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$35M24 Jun 2020 Baltimore, Maryland, United States

Biopharma
Biotechnology
Health Diagnostics
Medical
Wellness
$75M18 Jun 2019 Maryland, United States

NexImmune

Biopharma
Biotechnology
Therapeutics
$23M02 Jan 2018 Maryland, United States
Crunchbase icon

Content report

The following text will be sent to our editors: